3Buchbjerg T, Fristrup C, Mortensen MB. The incidence and prognosis of true duodenal careinomas [ J]. Surg Oncol, 2015, 24(2) :110-116.
4Hmluk MG, Devata S, Brown K. Should all patients with duodenal adenocareinoma be considered for aggssive surgical resection[ J] ? Arn J Surg, 2007, 193(3) :319-324.
5Cloyd JM, Norton JA, Visser BC, et al. Does the extent of resection impact survival for duodenal adenarcinoma? analysis ofl,611 cases[J]. AnnSurgOncol, 2015, 22(2) :573-580.
6Tocchi A,Mazzoni G, Tagliacozzo S, et al. Adenocarcinoma of the third and fourth portions of the duodenum : resuhs of surgical treatment [J]. Arch Surg, 2003, 138( 1 ) :80-85.
7Sohn TA,Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: faeto influencing long-term survival [ J ]. J Gastrointest Surg, 1998, 2( 1 ) :79-87.
8Bakaeen FG,Mmx MM, Sarr MG,et al. What prognostic factors are important in duodenal adenocarcinoma? [ J ]. Arch Surg, 2000, 135(6):635-641.
9Malleo G, Tonsi A, Marchegiani G, et al. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma [ J]. Langenbecks Arch SmH, 2013, 398 (3) : 287 -294.
10He J,Ahuja N, Makary MA, et al. 2564 resected periampullary adenocarcinomas at a single institution : trends over three decades [J]. HPB (Oxford), 2014, 16(1) :83-90.
